Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Chief Artificial Disc Replacement Innovator Dr. Todd Lanman Selected as Los Angeles' Premier Provider of New FDA-Approved Anatomical M6 Cervical Disc Device

Dr. Lanman to begin implanting M6 device in patients suffering from cervical disc degeneration as soon as June.


News provided by

Dr. Todd Lanman

Apr 23, 2019, 12:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Todd H. Lanman, Lanman Spinal Neurosurgery
Dr. Todd H. Lanman, Lanman Spinal Neurosurgery

LOS ANGELES, April 23, 2019 /PRNewswire-PRWeb/ -- Los Angeles spinal neurosurgeon Dr. Todd H. Lanman continues to be at the forefront of spinal artificial disc replacement technology, once again leading the release of a new FDA-approved disc replacement device with the M6-C, a device with the first-ever viscoelastic core, which for the first time will mimic the natural structure and movement of a human's cervical disc.

The founder of Beverly Hills-based practice Lanman Spinal Neurosurgery (http://www.spine.md), Dr. Lanman has been hand-selected as the premier provider in Greater Los Angeles and is expected to begin implanting this highly-advanced cervical disc replacement device in patients suffering from cervical disc degeneration disease as soon as June.

“Patients have shown the most enthusiasm about the M6 disc because of the normal compressibility and motion that the core of the disc provides, which mimics a normal human disc." - Dr. Todd H. Lanman

Post this

The currently available FDA approved artificial discs do not have compressibility like a normal human disc does, as they have been created with materials such as metals, ceramics and hard plastics. The M6-C by Orthofix is unique in that it mirrors the nuanced movement and normal compression of an anatomic cervical disc since the core of the M6 acts like a cushion just like a normal human disc.

At the 24-month mark, clinical patient outcomes have shown the M6-C device to demonstrate a statistically superior clinical improvement in the Neck Disability Index in 90.5 percent of patients, and nearly the same percentage (91.2 percent) in arm pain score, according to a U.S. Investigational Device Exemption study.

Says Dr. Lanman, "Of all the clinical trials for which I have served as the principal investigator of artificial discs in the cervical spine, patients have shown the most enthusiasm about the M6 disc because of the normal compressibility and motion that the core of the disc provides, which mimics a normal human disc."

The world of artificial disc replacement continues to march forward, providing an increased number of options for those looking to preserve movement and function at any age – and Dr. Lanman remains thoroughly committed to much of this innovation, most recently having been in the news cycle for leading similar advancements.

Last year, he became the first U.S. spine surgeon to begin offering a new procedure restoring movement, previously limited or completely restricted by those with one or more levels of fusion in the cervical spine, through the removal of such fusions and implantation of artificial disc replacement devices.

The year prior, he appeared on CBS' popular medical talk show "The Doctors" to reveal for the first time ever before a national audience a state-of-the-art two-level artificial disc replacement procedure using the Prestige LP device, for which he presided over its clinical trial as principal investigator leading to its FDA approval. The findings he released in the seven-year outcome released by the Journal of Neurosurgery demonstrated this procedure to be statistically superior to that of fusion, and relatively pain-free with rapid recovery time.        

This initial release of the M6-C device gives those suffering from cervical disc degeneration the chance to receive unparalleled care, relieving them of pain and restoring them to nearly or completely full motion and mobility with a more naturally moving disc device.    

As the leading specialist in the advancement of spinal health and surgery, total disc replacement and motion preservation for more than three decades, many of Dr. Lanman's patients include high-profile business leaders and executives, celebrities from the worlds of film, television, theater and music, and renowned sports players, who often travel from thousands of miles to receive his highly developed and superior medical care.

Dr. Todd H. Lanman's award-winning practice in the heart of Beverly Hills is affiliated with Cedars-Sinai Medical Center and UCLA Medical Center.

Lanman has published nearly a dozen peer-reviewed articles, as well as book chapters on topics relating to his area of medical expertise, and serves as a frequent media educator and contributor. In 2018, he was honored with the title of 'Leader in Health Care' by the Los Angeles Business Journal, taking home the prestigious award at the 2018 Health Care Leadership Forum & Awards.

SOURCE Dr. Todd Lanman

Related Links

http://www.spine.md

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.